Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1976 1
1980 1
2002 6
2003 4
2004 7
2005 7
2006 8
2007 7
2008 6
2009 11
2010 7
2011 15
2012 16
2013 10
2014 7
2015 14
2016 5
2017 12
2018 11
2019 10
2020 10
2021 12
2022 12
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Hepatitis E virus infection of transplanted kidneys.
Schmitz J, Kracht J, Evert K, Wenzel JJ, Schemmerer M, Lehmann U, Panning M, Pape L, Pohl M, Bräsen JH. Schmitz J, et al. Among authors: lehmann u. Am J Transplant. 2024 Mar;24(3):491-497. doi: 10.1016/j.ajt.2023.11.016. Epub 2023 Dec 10. Am J Transplant. 2024. PMID: 38072120 Free article.
[The IDH1/2 biomarker in tumor pathology].
Lehmann U, Stenzinger A. Lehmann U, et al. Pathologie (Heidelb). 2023 Sep;44(5):318-319. doi: 10.1007/s00292-023-01199-0. Epub 2023 May 30. Pathologie (Heidelb). 2023. PMID: 37249659 German. No abstract available.
[The biomarker PIK3CA in tumor pathology].
Lehmann U, Stenzinger A. Lehmann U, et al. Pathologie (Heidelb). 2023 Jul;44(4):259-260. doi: 10.1007/s00292-023-01190-9. Epub 2023 Mar 17. Pathologie (Heidelb). 2023. PMID: 36932239 German. No abstract available.
Variant classification in precision oncology.
Leichsenring J, Horak P, Kreutzfeldt S, Heining C, Christopoulos P, Volckmar AL, Neumann O, Kirchner M, Ploeger C, Budczies J, Heilig CE, Hutter B, Fröhlich M, Uhrig S, Kazdal D, Allgäuer M, Harms A, Rempel E, Lehmann U, Thomas M, Pfarr N, Azoitei N, Bonzheim I, Marienfeld R, Möller P, Werner M, Fend F, Boerries M, von Bubnoff N, Lassmann S, Longerich T, Bitzer M, Seufferlein T, Malek N, Weichert W, Schirmacher P, Penzel R, Endris V, Brors B, Klauschen F, Glimm H, Fröhling S, Stenzinger A. Leichsenring J, et al. Among authors: lehmann u. Int J Cancer. 2019 Dec 1;145(11):2996-3010. doi: 10.1002/ijc.32358. Epub 2019 May 21. Int J Cancer. 2019. PMID: 31008532 Free article.
FGFR inhibitors in cholangiocarcinoma: what's now and what's next?
Saborowski A, Lehmann U, Vogel A. Saborowski A, et al. Among authors: lehmann u. Ther Adv Med Oncol. 2020 Sep 16;12:1758835920953293. doi: 10.1177/1758835920953293. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32983265 Free PMC article. Review.
[The biomarker POLE in tumor pathology].
Lehmann U, Stenzinger A. Lehmann U, et al. Pathologie (Heidelb). 2024 Feb;45(1):67-68. doi: 10.1007/s00292-023-01284-4. Epub 2023 Dec 5. Pathologie (Heidelb). 2024. PMID: 38051340 German. No abstract available.
189 results